Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML
Clinical trial NCT02560025 · COMPLETED
Trial details
- NCT number
- NCT02560025
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-10-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.